Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe

Abstract

Given the current financial climate there is an ever increasing need to substitute drug treatments to optimize \nexpenditure. A closer examination of the beliefs surrounding \nwhen substitution is appropriate led a group of European \nhealthcare experts to argue that in some cases these \nbeliefs may be unfounded and that guidelines are needed \nfor clinical practice.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 48 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.